Blog

Startup Palleon has a sweet plan for cancer immunotherapy – FierceBiotech


FierceBiotech

Startup Palleon has a sweet plan for cancer immunotherapy
FierceBiotech
Startup Palleon has a sweet plan for cancer immunotherapy. by Phil Taylor |. Oct 4, 2017 9:25am. Glycan-sensing checkpoints enable both innate and adaptive immune responses to cancer, says Jim Broderick, M.D., Palleon's CEO and founder.

and more »

2017-10-04 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.